Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 60 of 95, showing 5 Applications out of 471 total, starting on record 296, ending on 300

# Protocol No Study Title Investigator(s) & Site(s)

296.

ECCT/24/05/03   SIBP-MMR-02
    A Phase III, Multi-Center, Randomized, Observer-Blind, Active Controlled Non-Inferiority Study to Evaluate the Immunogenicity and Safety of Shanghai Institute of Biological Products Co., Ltd.’s Measles, Mumps and Rubella (MMR) Vaccine Compared to a Licensed and WHO Prequalified GSK MMR Vaccine in Healthy African Children, 9- 11 Months of Age   
Principal Investigator(s)
1. Dr Walter Otieno
2. Dr. Diana Odhiambo
Site(s) in Kenya
1. Victoria Biomedical Research Institute (Kisumu county)
2. Victoria Biomedical Research Institute (Kisumu county)
3. Victoria Biomedical Research Institute (Kisumu county)
 
View

297.

ECCT/11/08/03   Compare the Efficacy and Safety of Gentian Violet to that of Nystatin
    A Phase III, Open-Label, Randomized, Assessment-Blinded Clinical Trial to Compare the Safety and Efficacy of Topical Gentian Violet to that of Nystatin Oral Suspension for the Treatment of Oropharyngeal Candidiasis in HIV-1 Infected Participants in Non-U.S. Settings   
Principal Investigator(s)
1. Deborah C Langat
Site(s) in Kenya
1. Kenya Medical Research Institute Walter Reed Project Clinical Research Centre (Kericho county)
2. Moi University Clinical Research Centre (Uasin Gishu county)
 
View

298.

ECCT/15/03/01   A phase III, non-inferiority trial using Carbetocin room temperature stable (RTS) for the prevention of postpartum haemorrhage during the third stage of labour in women delivering
    A phase III, randomized, double-blind, active, controlled, multinational, multicentre,  non-inferiority trial using Carbetocin room temperature stable (RTS) for the prevention of postpartum haemorrhage during the third stage of labour in women delivering vaginally.   
Principal Investigator(s)
1. Zahida Qureshi
Site(s) in Kenya
Kenyatta National Hospital
 
View

299.

ECCT/23/06/05   ARNASA
    A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ASTEGOLIMAB IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE   
Principal Investigator(s)
1. Jesse Gitaka
Site(s) in Kenya
1. Center for Research In Tropical Medicine and Community Development (Nairobi City county)
2. Clinical Research Health Network (CREA-N) (Machakos county)
3. KEMRI-CRDR Siaya Clinical Research Annex (Siaya county)
4. KEMRI-Mtwapa Clinical Annex (Kilifi county)
5. University of Nairobi Clinical Research Centre (Nairobi City county)
6. KEMRI-CRDR Clinical Research Annex (Nairobi City county)
 
View

300.

ECCT/23/09/01   ARNASA
    A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ASTEGOLIMAB IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE   
Principal Investigator(s)
1. Dr Mary Matilu
Site(s) in Kenya
1. KEMRI-Mtwapa Clinical Research Annex, (Kilifi county)
2. University of Nairobi Clinical Research Centre (Nairobi City county)
3. Center for Research In Tropical Medicine and Community Development (Nairobi City county)
4. Clinical Research Health Network (CREA-N) (Machakos county)
5. KEMRI-CRDR Siaya Clinical Research Annex (Siaya county)
6. KEMRI-CRDR Clinical Research Annex (Nairobi City county)
7. Clinical Research Health Network (CREA-N) (Machakos county)
 
View